SE434741B - Oxazetidinderivat till anvendning som mellanprodukt vid framstellning av metylpenam-, cefam-, och -cefamforeningar - Google Patents

Oxazetidinderivat till anvendning som mellanprodukt vid framstellning av metylpenam-, cefam-, och -cefamforeningar

Info

Publication number
SE434741B
SE434741B SE7510791A SE7510791A SE434741B SE 434741 B SE434741 B SE 434741B SE 7510791 A SE7510791 A SE 7510791A SE 7510791 A SE7510791 A SE 7510791A SE 434741 B SE434741 B SE 434741B
Authority
SE
Sweden
Prior art keywords
cefam
oxazetide
methylpenam
derivatives
compounds
Prior art date
Application number
SE7510791A
Other languages
English (en)
Other versions
SE7510791L (sv
Inventor
T Kamiya
Y Saito
T Teraji
M Hashimoto
O Nakaguti
T Oku
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4615871A external-priority patent/JPS5632306B1/ja
Priority claimed from JP6177671A external-priority patent/JPS557432B2/ja
Priority claimed from JP6177771A external-priority patent/JPS5442995B2/ja
Priority claimed from JP6268771A external-priority patent/JPS5442996B2/ja
Priority claimed from JP46063885A external-priority patent/JPS4829759A/ja
Priority claimed from JP6388671A external-priority patent/JPS5614664B2/ja
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of SE7510791L publication Critical patent/SE7510791L/sv
Publication of SE434741B publication Critical patent/SE434741B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
SE7510791A 1971-06-24 1975-09-25 Oxazetidinderivat till anvendning som mellanprodukt vid framstellning av metylpenam-, cefam-, och -cefamforeningar SE434741B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP4615871A JPS5632306B1 (sv) 1971-06-24 1971-06-24
JP6177671A JPS557432B2 (sv) 1971-08-14 1971-08-14
JP6177771A JPS5442995B2 (sv) 1971-08-14 1971-08-14
JP6268771A JPS5442996B2 (sv) 1971-08-18 1971-08-18
JP46063885A JPS4829759A (sv) 1971-08-21 1971-08-21
JP6388671A JPS5614664B2 (sv) 1971-08-21 1971-08-21

Publications (2)

Publication Number Publication Date
SE7510791L SE7510791L (sv) 1975-09-25
SE434741B true SE434741B (sv) 1984-08-13

Family

ID=27550224

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7510791A SE434741B (sv) 1971-06-24 1975-09-25 Oxazetidinderivat till anvendning som mellanprodukt vid framstellning av metylpenam-, cefam-, och -cefamforeningar

Country Status (1)

Country Link
SE (1) SE434741B (sv)

Also Published As

Publication number Publication date
SE7510791L (sv) 1975-09-25

Similar Documents

Publication Publication Date Title
SE422460B (sv) 1,5-bensodiazocinderivat till anvendning som mellanprodukt for framstellning av 1,4-bensodiazepiner samt sett for framstellning derav
SE382459B (sv) Forfarande for framstellning av xantonderivat.
SE390967B (sv) Tiokarbamider till anvendning som mellanprodukter vid framstellning av isotiokarbamider med farmaceautisk verkan
SE393800B (sv) Forfarande for framstellning av bensoylamino-alkyl-fenoxi-alkylkarbonsyraderivat med lipidsenkande effekt
SE400280B (sv) 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE430605B (sv) Forening for anvendning som mellanprodukt vid framstellning av ftalidestrar av penicilliner
NO145884C (no) 7-methoxy-7-aminocefalosporansyreforbindelser for anvendelse som utgangsmaterialer ved fremstilling av 7-methoxy-7-acylaminocefalosporansyrederivater
SE384504B (sv) 6-substituerade-4-halogen-1,2-dihydro-1-hydroxi-2-iminopyrimidiner till anvendning vid framstellning av motsvarande 4-aminoforeningar
SE400555B (sv) N-substituerade beta-amino-alfa-bensylakrylnitrilforening till anvendning som mellanprodukt vid framstellning av 5-bensyl-pyrimidiner
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE393374B (sv) Forfarande for framstellning av 2-alkyl-2-dialkylamino-2, '6'-acetoxylidider med lokalestetisk effekt
SE431756B (sv) Fenoxi-2-oxopropylfosfonat till anvendning som mellanprodukt vid framstellning av nya w-pentanorprostaglandiner
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
SE396592B (sv) Foreningen difluorometyl-2,2,3,3-tetrafluoropropyleter till anvendning som mellanprodukt vid framstellning av difluormetyl-1,2,2,3,3-pentafluoropropyleter
SE399879B (sv) Kemiska mellanprodukter till anvendning for framstellning av terapeutiskt verdefulla 1,2,3,4-tetrahydro-4-fenyl-isokinolinderivat
SE419089B (sv) Organosilanpenicillin anvaendbar som mellanprodukt vid framstaellning av penicilliner
SE423098B (sv) Forening till anvendning vid framstellning av cefalosporansyraforeningar
SE388415B (sv) N,n-dietyl-n,n'-di-n-butylkarbamid till anvendning som losningsmedel for en lengre alkylantrakinon vid framstellning av veteperoxid
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE7700287L (sv) Nya foreningar till anvendning som mellanprodukter vid framstellning av aminosubstituerade tetracykliska foreningar
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
NO137597C (no) Xantonderivater for bruk som mellomprodukter ved fremstilling av terapeutisk virksomme forbindelser
SE383738B (sv) Forfarande for framstellning av sulfamoyl-bensensulfonamider med terapeutiska egenskaper
SE434741B (sv) Oxazetidinderivat till anvendning som mellanprodukt vid framstellning av metylpenam-, cefam-, och -cefamforeningar
SE384511B (sv) 7-skyddad amino-delta?722?71-cefalosporansyraester, for anvendning som mellanforening vid framstellning av delta?723?71-cefalosporinantibiotika

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7510791-2

Effective date: 19920704

Format of ref document f/p: F